The horseshoe kidney is one of the most common congenital disorders affecting the urogenital system. Following a fusion of the lower kidney poles, which in turn lead to the formation of an isthmus, this anatomical variation is accompanied by other characteristic properties like an incomplete ascension, ventral rotation of the pelvices as well as atypical vascular supply. Even though renal carcinoids and Wilms tumors are more common in horseshoe kidneys, the incidence of renal cell carcinomas seems to be unaffected. Here we report the case of a locally advanced renal cell carcinoma with extensive venous invasion occurring in a horseshoe kidney and its complex surgical management. The whole primary tumor as well as a majority of venous tumor thrombi could be removed by a combination of 2/3 nephrectomy and cavotomy with thrombectomy. During 1 year of follow-up, the patient neither suffered from a tumor relapse, nor did he require renal replacement therapy. Thus, we conclude that even in cases of RCC where advanced disease is associated with complex anatomical situations, organ-preserving surgical treatment should be pursued to achieve excellent functional and oncological results.

Keywords:
Horseshoe kidney, Renal cell carcinoma, Venous tumor thrombus, Organ preservation
1.
Jones DJ, Wickham JE, Kellett MJ: Percutaneous nephrolithotomy for calculi in horseshoe kidneys. J Urol 1991;145:481-483.
2.
Cocheteux B, Mounier-Vehier C, Gaxotte V, McFadden EP, Francke JP, Beregi JP: Rare variations in renal anatomy and blood supply: CT appearances and embryological background. A pictorial essay. Eur Radiol 2001;11:779-786.
3.
Natsis K, Piagkou M, Skotsimara A, Protogerou V, Tsitouridis I, Skandalakis P: Horseshoe kidney: a review of anatomy and pathology. Surg Radiol Anat 2014;36:517-526.
4.
Evans WP, Resnick MI: Horseshoe kidney and urolithiasis. J Urol 1981;125:620-621.
5.
Huang EY, Mascarenhas L, Mahour GH: Wilms' tumor and horseshoe kidneys: a case report and review of the literature. J Pediatr Surg 2004;39:207-212.
6.
Krishnan B, Truong LD, Saleh G, Sirbasku DM, Slawin KM: Horseshoe kidney is associated with an increased relative risk of primary renal carcinoid tumor. J Urol 1997;157:2059-2066.
7.
Heng DY, Wells JC, Rini BI, Beuselinck B, Lee JL, Knox JJ, Bjarnason GA, Pal SK, Kollmannsberger CK, Yuasa T, Srinivas S, Donskov F, Bamias A, Wood LA, Ernst DS, Agarwal N, Vaishampayan UN, Rha SY, Kim JJ, Choueiri TK: Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the international metastatic renal cell carcinoma database consortium. Eur Urol 2014;66:704-710.
8.
Abel EJ, Wood CG, Eickstaedt N, Fang JE, Kenney P, Bagrodia A, Youssef RF, Sagalowsky AI, Margulis V: Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus. J Urol 2013;190:452-457.
9.
Ljungberg B, Stenling R, Osterdahl B, Farrelly E, Aberg T, Roos G: Vein invasion in renal cell carcinoma: impact on metastatic behavior and survival. J Urol 1995;154:1681-1684.
10.
Janitzky A, Meyer F, Halloul Z, Porsch M, Daher M, Kuester D, Pech M, Liehr UB: Successful interdisciplinary treatment of renal cell carcinoma with tumour thrombus into inferior vena cava using multimodal protocol and organ-extending R0 resection in rare horseshoe kidney and doubled right organ. BMJ Case Rep 2010;pii:bcr0420091802.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.